FSIPP/FSPMR Tampa 2021 - Archive Block 5

ReachMD Healthcare Image

The live program has concluded.


If you attended, please click on the "Take Post-Test" button to claim your credit. If you did not attend, please stay tuned for the archived version, which will be available soon for on-demand viewing.

Details
  • Overview

    This content was recorded as part of FSIPP/FSPMR Interventional Pain Management 2021

    Pain management and interventional pain management are quickly growing fields in medicine. Emerging science and treatment options for patient care are growing rapidly and it is important for clinicians specializing in this field of medicine to know, understand and evaluate available options to be able to continue to provide the best treatment options and quality of care for patients. Additionally, this field of medicine is subject to higher than normal scrutiny, liability and litigiousness stemming from alleged over treatment and under treatment of care. It is vitally important for clinicians to understand best practices and practice guidelines to insure that they are offering the best care, remaining in compliance to lessen exposure and liability while still insuring access to care and the best treatment outcomes for patients.

    This certified CME activity will unite pain practitioners from across the United States, Europe & Caribbean including; engineers, researchers, anesthesiologists, neurosurgeons, neurologists, pain medicine specialists, and venture capitalists. FSIPP and FSPM&R will feature an interventional pain medicine faculty, some nationally and internationally recognized. This content led conference will help the interventional pain medicine practitioner expand and update existing knowledge/skills regarding ever-increasingly sophisticated diagnostic and practice guidelines, to share new ideas for evaluation and treatment techniques, and to increase the practitioner’s knowledge and ability to act and advocate for patients within the current medical legislative and regulatory environment.

    Please click on Begin Course to access your evaluation and certificate.

    Supported by an unrestricted educational grant from Abbott, Boston Scientific, and Medtronic.

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Discuss the basic science behind stimulation techniques for interventional pain therapies.
    • Understand the process and limitations of bringing a product or device through basic science research.
    • Explore avenues to encourage original research.
    • Accreditation

      Jointly Provided by Evolve Medical Education, LLC and Mantra Meetings. 

             

      This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education, LLC and Mantra Meetings. Evolve Medical Education, LLC is accredited by the ACCME to provide continuing medical education for physicians.
      Physicians
      Evolve Medical Education designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit™.
      Physicians should claim only the credit commensurate with the extent of their participation in the activity.
      Nurses
      Evolve Medical Education, LLC is an approved provider by the California Board of Registered Nursing, Provider Number 17004 for 2.0 contact hours.

    • Participation Method

      In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

      Course Viewing Requirements

      Supported Browsers:
      Internet Explorer 11 for Windows
      Edge (recent versions; Chromium-based) for Windows
      Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
      Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
      Safari (recent versions) for Mac OSX, or iOS

      Hardware Requirements:
      4GB+ RAM
      Recommended internet speed 5Mbps+

    • Faculty and Disclosures

      Miguel de la Garza, MD, DABA, DABPM

      Miguel de la Garza, MD, DABA, DABPM

      Course Director
      Partner
      Comprehensive Pain Management Partners
      New Port Richey, FL


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

      The following faculty/staff members have the following financial relationships with commercial interests:

      Miguel de la Garza, MD, DABA, DABPM, has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: BDSI, Baudax Bio, Boston Scientific; Grant/Research Support: Baudax Bio; Speaker's Bureau: BDSI, Baudax Bio, Boston Scientific.

      Ricardo Vallejo, MD, PhD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Medtronic; Speaker’s Bureau: Medtronic; Shareholder: SGX-Medical

      Ajay Antony, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Boston Scientific, PainTEQ; Grant/Research Support: Abbott, Boston Scientific, Nalu, PainTEQ, SPR Therapeutics.

      Michael F. Esposito, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Boston Scientific, Medtronic, Nevro; Grant/Research Support: Abbott, Boston Scientific, Medtronic, Nevro, CornerLoc; Speaker's Bureau: Abbott, Boston Scientific, Medtronic, Nevro.

      Quang “Wayne” Nguyen, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Vertos Medical, Omnia Medical, Nevro, NuTech Spine; Grant/Research Support: Vertos Medical.

      Robert Ball, DO, MS, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Nevro, Abbott, Vertos Medical; Grant/Research Support: Nalu, Boston Scientific (Vertiflex); Speaker’s Bureau: Abbott, Relievant.

      Kenneth D. Candido, MD, has no financial relationships to disclose.

      Sean Li, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Avanos, Biotronik, Boston Scientific, Nalu, Nevro Corp., PainTEQ, Saluda Medical, SI-BONE, SPR Therapeutics, Vertos Medical; Grant/Research Support: Avanos, Biotronik, Boston Scientific, Nevro Corp., Saluda Medical, SGX Medical, SPR Therapeutics; Speaker's Bureau: Gruenthal Pharmaceuticals; Shareholder: Nalu, National Spine and Pain Centers.

      Peter S. Staats, MD, MBA, FIPP, ABIPP, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: National Spine & Pain Centers; Shareholder: electroCore, National Spine & Pain Centers, Saluda Medical, SPR Therapeutics; Other Financial/Material Support: electroCore.

      Andrea Trescot, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Other Financial/Material Support: Stimwave Technologies.

      The Evolve staff/planners and Mantra Meetings staff/planners have no financial relationships with commercial interests.

      Deborah H. Tracy MD, MBA, Rene Przkora, MD, PhD, Sanford M. Silverman, MD, and Mark Rubenstein, MD, PA, peer reviewers, have no financial relationships with commercial interests.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Mantra Meetings, the Florida Society of Interventional Pain Physicians (FSIPP), the Florida Society of Physical Medicine and Rehabilitation (FSPM&R), Abbott, Boston Scientific, or Medtronic.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Expiration Date:

    2.00 credits
    Completing the pre-test is required to access this content.
    Completing the pre-survey is required to view this content.

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    Register

    We're glad to see you're enjoying Evolve Medical Education…
    but how about a more personalized experience?

    Register for free